Garbe C - Search Results

1

Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade.

Bochem J, Zelba H, Amaral T, Spreuer J, Soffel D, Eigentler T, Wagner NB, Uslu U, Terheyden P, Meier F, Garbe C, Pawelec G, Weide B, Wistuba-Hamprecht K. Bochem J, et al. Among authors: garbe c. PLoS One. 2019 Aug 16;14(8):e0221301. doi: 10.1371/journal.pone.0221301. eCollection 2019. PLoS One. 2019. PMID: 31419253 Free PMC article.

2

Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy.

Garbe C, Paul A, Kohler-Späth H, Ellwanger U, Stroebel W, Schwarz M, Schlagenhauff B, Meier F, Schittek B, Blaheta HJ, Blum A, Rassner G. Garbe C, et al. J Clin Oncol. 2003 Feb 1;21(3):520-9. doi: 10.1200/JCO.2003.01.091. J Clin Oncol. 2003. PMID: 12560444

3

Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients.

Garbe C, Leiter U, Ellwanger U, Blaheta HJ, Meier F, Rassner G, Schittek B. Garbe C, et al. Cancer. 2003 Apr 1;97(7):1737-45. doi: 10.1002/cncr.11250. Cancer. 2003. PMID: 12655531 Free article.

4

Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials.

Eigentler TK, Caroli UM, Radny P, Garbe C. Eigentler TK, et al. Among authors: garbe c. Lancet Oncol. 2003 Dec;4(12):748-59. doi: 10.1016/s1470-2045(03)01280-4. Lancet Oncol. 2003. PMID: 14662431 Review.

5

The natural course of cutaneous melanoma.

Leiter U, Meier F, Schittek B, Garbe C. Leiter U, et al. Among authors: garbe c. J Surg Oncol. 2004 Jul 1;86(4):172-8. doi: 10.1002/jso.20079. J Surg Oncol. 2004. PMID: 15221923 Review.

6

Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.

Leiter U, Buettner PG, Eigentler TK, Garbe C. Leiter U, et al. Among authors: garbe c. J Clin Oncol. 2004 Sep 15;22(18):3660-7. doi: 10.1200/JCO.2004.03.074. Epub 2004 Aug 9. J Clin Oncol. 2004. PMID: 15302905

7

Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.

Eigentler TK, Buettner PG, Leiter U, Garbe C; Central Malignant Melanoma Registry of the German Dermatological Society. Eigentler TK, et al. Among authors: garbe c. J Clin Oncol. 2004 Nov 1;22(21):4376-83. doi: 10.1200/JCO.2004.03.075. J Clin Oncol. 2004. PMID: 15514379

8

Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.

Buettner PG, Leiter U, Eigentler TK, Garbe C. Buettner PG, et al. Among authors: garbe c. Cancer. 2005 Feb 1;103(3):616-24. doi: 10.1002/cncr.20816. Cancer. 2005. PMID: 15630700 Free article.

9

Imiquimod in the treatment of extensive recurrent lentigo maligna.

Kamin A, Eigentler TK, Radny P, Bauer J, Weide B, Garbe C. Kamin A, et al. Among authors: garbe c. J Am Acad Dermatol. 2005 Feb;52(2 Suppl 1):51-2. doi: 10.1016/j.jaad.2004.07.047. J Am Acad Dermatol. 2005. PMID: 15692515

10

[Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].

Eigentler TK, Radny P, Kamin A, Weide B, Caroli UM, Garbe C. Eigentler TK, et al. Among authors: garbe c. J Dtsch Dermatol Ges. 2005 Aug;3(8):592-8. doi: 10.1111/j.1610-0387.2005.05051.x. J Dtsch Dermatol Ges. 2005. PMID: 16033477 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

801 results

Search Page

Filters